Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

Sensex Trades Marginally Higher; L&T and Infosys Top Gainers
Thu, 23 Jan 12:30 pm

Editor's note: Dear reader, we are now on Telegram! Get our latest views on stock markets and more, instantly. Join our Telegram channel here!


Share markets in India are presently trading on a positive note. The BSE Sensex is trading up by 92 points, while the NSE Nifty is trading up by 25 points.

The BSE Mid Cap index is trading up by 0.8%, while the BSE Small Cap index is trading up by 0.6%.

Barring FMCG stocks, all sectoral indices are trading in green with stocks in the capital goods sector and realty sector witnessing most of the buying interest.

The rupee is currently trading at Rs 71.23 against the US$.

In news from the pharma sector, Alembic Pharma share price is in focus today.

The pharma company on Tuesday reported its consolidated financial results for the quarter ending December 31, 2019.

The company's revenues for the quarter were up 19% YoY at Rs 12.1 billion as against Rs 10.2 billion in Q3FY19.

Net profit for the quarter was up 33% YoY to Rs 2.3 billion from Rs 1.7 billion last year.

International formulations grew 48% YoY to Rs 6.6 billion in the quarter. US Generics grew 61% to Rs 5.2 billion. Ex-US Sales grew 15% to Rs 1.5 billion in the quarter.

The India formulations business was Rs 3.7 billion for the quarter. The company received 8 ANDA approvals during the quarter and the total tally stood at 110.

To know more about the company, you can read Alembic Pharma's latest result analysis on our website.

Speaking of the pharma sector, in the video below, Tanushree talks in great detail about where the sector stands now and also about its potential for a rebound.

Tune in to find out more...

Moving on, as per an article in a leading financial daily, new demat accounts and the total number of such accounts hit a 10-year high in 2019.

While new demat account openings rose 12.5% from the previous year to touch 4.5 million, total demat accounts at the end of 2019 stood at 39.3 million, up from 34.8 million in 2018.

Reports state that policy changes like easier know-your-customer (KYC) norms, greater internet penetration, affordable devices and technology, which enabled easy access to services have increased the financialization of savings.

Note that mutual funds have also attracted retail investors, with money collected through systematic investment plans (SIPs) showing a growth trend. Total money collected through SIPs was Rs 986.1 billion in 2019.

According to data from the Association of Mutual Funds in India, there are 87.13 million accounts in the mutual fund industry as of December 2019, of which 89.8% is accounted for by retail investors.

There were 78.2 million retail investor accounts, 8.2 million high net worth individuals (HNI) accounts and 0.7 million institutional investor accounts. Since December 2014, there is an increase in investor accounts from 40.3 million to 87.1 million in December 2019.

Assets managed by the Indian mutual fund industry have grown from Rs 24.09 trillion in December 2018 to Rs 27.26 trillion in December 2019, representing a 13.2% growth in assets over December 2018.

Speaking of the mutual fund industry, note that the Indian mutual fund industry is a high growth sector.

In fact, the growth rate over the last five years has been even higher. The chart below shows the trend in mutual fund AUMs since FY14.

Mutual Fund AUM Tripled in Just 5 years

Over the last five years, mutual fund AUMs have nearly tripled, growing at 23.5% CAGR.

Recently, NSE-backed Computer Age Management Services (CAMS) filed a draft red herring prospectus with the market regulator. CAMS is the largest registrar and transfer agent (RTA) for mutual funds in India.

Being the largest registrar and transfer agent for mutual funds, CAMS is a direct beneficiary of the twin megatrends of financialisation and digitalisation.

Ankit is closely tracking this IPO and will be sharing his views at his premium newsletter Equitymaster Insider (requires subscription).

He's also closely watching the IPO trend in 2020 and is going to pick all the profitable IPOs for his readers at Equitymaster Insider. In one of his recent articles, he has explained why keeping a tab on the IPO market is vital to your overall investing goals. You can read it here: What I Learnt from IPOs in 2019 (requires subscription).

To know what's moving the Indian stock markets today, check out the most recent share market updates here.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Sensex Trades Marginally Higher; L&T and Infosys Top Gainers". Click here!